Cite
72PD LOBECTOMY IN COMBINATION WITH RADICAL LYMPHADENECTOMY IS THE MOST FREQUENT SURGICAL INTERVENTION PERFORMED IN PATIENTS RANDOMIZED IN MAGRIT TRIAL EVALUATING MAGE-A3 ANTIGEN-SPECIFIC CANCER IMMUNOTHERAPEUTIC (ASCI) AS ADJUVANT TREATMENT IN STAGE IB IIIA NSCLC
MLA
Zielinski, M., et al. “72Pd Lobectomy in Combination with Radical Lymphadenectomy Is the Most Frequent Surgical Intervention Performed in Patients Randomized in Magrit Trial Evaluating Mage-A3 Antigen-Specific Cancer Immunotherapeutic (Asci) as Adjuvant Treatment in Stage Ib Iiia Nsclc.” Lung Cancer (01695002), vol. 71, Feb. 2011, pp. S37–38. EBSCOhost, https://doi.org/10.1016/S0169-5002(11)70209-4.
APA
Zielinski, M., Zo, J., Vanakesa, T., Dahabreh, J., Hoffmann, H., Holzer, M., Mitsudomi, T., Tada, H., Asamura, H., & Debruyne, C. (2011). 72Pd Lobectomy in Combination with Radical Lymphadenectomy Is the Most Frequent Surgical Intervention Performed in Patients Randomized in Magrit Trial Evaluating Mage-A3 Antigen-Specific Cancer Immunotherapeutic (Asci) as Adjuvant Treatment in Stage Ib Iiia Nsclc. Lung Cancer (01695002), 71, S37–S38. https://doi.org/10.1016/S0169-5002(11)70209-4
Chicago
Zielinski, M., J. Zo, T. Vanakesa, J. Dahabreh, H. Hoffmann, M. Holzer, T. Mitsudomi, H. Tada, H. Asamura, and C. Debruyne. 2011. “72Pd Lobectomy in Combination with Radical Lymphadenectomy Is the Most Frequent Surgical Intervention Performed in Patients Randomized in Magrit Trial Evaluating Mage-A3 Antigen-Specific Cancer Immunotherapeutic (Asci) as Adjuvant Treatment in Stage Ib Iiia Nsclc.” Lung Cancer (01695002) 71 (February): S37–38. doi:10.1016/S0169-5002(11)70209-4.